Abstract: The present study deals with the circadian expression of clock genes in acute cardiac death to examine any correlation between clock gene expression and catecholamines. A total of 36 subjects, who died of acute ischemic heart disease (AIHD, n = 10), acute myocardial infarction (AMI, n = 11), and recurrent myocardial infarction (RMI, n = 15) and underwent autopsy within 2 days after death, were included in this study. The mRNA expression levels of the clock genes BMAL1, PER2, and REV-ERBα were determined in the post-mortem heart tissue. Catecholamine levels in blood obtained from the right heart were measured. Furthermore, the cellular localization of clock proteins was assessed by immunohistochemistry, and protein levels in the heart tissue were also measured by Western blotting. In our cases of AIHD death, BMAL1 and PER2 exhibited trimodal expression patterns; however, the trimodal expression pattern of PER2 was antiphasic to that of BMAL1. PER2 expression correlated with adrenaline and noradrenaline levels. In deaths from AMI, BMAL1 and PER2 exhibited antiphasic trimodal and bimodal expressions, respectively, and BMAL1 expression correlated with adrenaline and noradrenaline levels. In RMI, both BMAL1 and PER2 exhibited antiphasic unimodal expression patterns, which were not correlated with adrenaline and noradrenaline levels. REV-ERBα expression varied, and no correlations were found between dopamine levels and clock gene expression in any group. We concluded that catecholamine levels are decreased in AIHD and raised in AMI as a function of BMAL1 expression and that BMAL1 and PER2 modulate and suppress catecholamine levels respectively.
Introduction
Several physiological functions of the cardiovascular systems such as heart rate and blood pressure show apparent circadian variation 1) . In addition, many cardiovascular disorders follow a circadian pattern. For example, acute myocardial infarction (AMI) and cerebral infarction most often occur in the early morning, whereas subarachnoid hemorrhage and a subtype of atrial fi brillation are usually observed in the afternoon. Diurnal variation in cardiovascular events is regarded as a consequence of both the external and internal biological clock. The circadian rhythm and the increased incidence of cardiovascular events in the second quarter of the day may be due to autonomic modulation as well as an increased excitability of brain and heart tissue.
Molecular mechanisms regulating the biological clock have been extensively studied 2) . However, only a few studies have examined the biological clock genes in relation to disease in the forensic medicine fi eld 3) . Both physiological and pathological functions of cardiovascular organs are closely related to the endogenously driven 24-h cycle of the circadian rhythm. Heart rate, blood pressure, and endothelial function show diurnal variations within the day 4) . One of the best known examples in humans is the daily oscillation in blood pressure, which peaks during the day and dips at night 5, 6) . These rhythmic oscillations are important to the health of the organism and have evolved to anticipate the timing of physiological demands. Disruption of circadian rhythms through changes in environmental cues leads to an increased incidence of cardiovascular diseases in animals and was shown to correlate with an increased risk of death in humans 7, 8) . Experiments in mice have apparently shown such correlations, and this study is an attempt to replicate similar fi ndings in human autopsy cases.
Heart attacks and strokes exhibit a daily rhythm 9) , and the significance of the relationship between cardiovascular disease and circadian rhythm was directly demonstrated in mice with genetic disruption of the circadian clock that resulted in impaired endotheliumdependent relaxation 10) , exaggerated vascular remodeling 11, 12) , altered cardiac ischemia reperfusion 13) , increased atherosclerosis 14, 15) , and impaired blood pressure control 16) . Thus, peripheral clocks located in organs of the cardiovascular system such as the heart 17, 18) , the kidneys 19) , and the blood vessels 12) play an important role in the regulation of local physiology. However, the correlation between human clock gene expression and factors precipitating acute cardiac death such as catecholamines is not clear.
Therefore, we investigated the circadian expression of clock genes in acute cardiac deaths to examine the correlation between human clock gene expression and catecholamines that stimulate signaling. toxicological findings, the cause of death was classified as acute ischemic heart disease (AIHD, n=10), acute myocardial infarction (AMI, n=11), or recurrent myocardial infarction (RMI, n=15). AMI and RMI cases included those with relevant coronary lesions (stenosis >75%) and/or thrombus.
Specimens from the anterior, lateral, and septal regions of the left ventricular wall as well as the right lateral ventricular myocardium were histopathologically assessed by routine hematoxylin and eosin (HE) staining. The main histopathological criteria were as follows 20, 21) : AMI, a focal ischemic myocardial lesion showing eosinophilic change of cardiomyocytes with interstitial hemorrhage and/or necrosis related to a coronary lesion; RMI, a focal ischemic myocardial lesion accompanied by the scar of old infarction; and AIHD, diff use interstitial congestion, edema, and patchy myocardial eosinophilic changes without any blockshaped myocardial necrosis 22) . The AMI group included a 30-yearold woman; however, this case showed clearly necrotic fi ndings of the myocardium and thrombosis of the left anterior descending coronary artery.
The postmortem interval was defined as the time from estimated time of death to the autopsy. Survival time was the period from the onset of the fatal insult until death. For this purpose, we used only cases where the insult was witnessed and/or circumstantial evidence was well established to confi rm survival and postmortem times, conforming to estimates based on the classic pathologic fi ndings 20, [22] [23] [24] [25] . In this study, none of the patients were known to have been receiving medical care. Therefore, details of their medical history were unavailable. However, on toxicological testing, no cardiovascular medications that might have been prescribed, including beta blockers, were detected. Cases with catecholamine use for cardiopulmonary resuscitation and those with temporary survival following cardiopulmonary resuscitation were excluded. Cohort characteristics are shown in Table 1 .
Myocardial tissue specimens were taken from fi ve consistent sites: left anterior ventricular wall (A), left posterior ventricular wall (B), right ventricular wall (C), left atrium (D), and right atrium (E). The tissue samples were immediately immersed in 1 ml RNA stabilization solution (RNAlaterTM, Ambion, Austin, TX, USA) and stored at -80°C until use. In AMI and RMI cases showing gross myocardial necrosis, separate specimens were taken from regions showing necrosis as well as regions with an intact appearance 22) . Right heart blood was collected aseptically using a syringe at autopsy for immediate measurement of catecholamines. Routine heart tissue specimens were preserved in formalin for histopathology.
Extraction of total RNA and cDNA synthesis
Total RNA was isolated using Isogen (Nippon Gene, Toyama) according to the manufacturer's instructions. cDNA copies of total RNA were synthesized using the High Capacity RNA-to-cDNA kit (Applied Biosystems Japan). The reaction mixture included 9 µl samples of total RNA, 10.0 µl 2×RT Buff er, and 1.0 µl 20×RT enzyme mix. Conditions for reverse transcription were 37°C for 60 min and 95°C for 5 min 22) .
Reference gene selection
Taqman® Express human endogenous control plates (Applied Biosystems, Foster City, USA) containing fi ve candidate genes selected from a literature search were used 26) . Applied Biosystems declared that all assays were designed using the same algorithm and were extensively tested. We tested the stability of endogenous reference genes in postmortem myocardial tissue. The following fi ve endogenous reference genes were used: ecukaryotic 18S rRNA (18S, TaqMan assay ID: Hs99999901_sl), glyceraldehyde-3-phosphoribosyltransferase 1 (GAPDH, TaqMan assay ID: Hs99999905_ml), TATA-binding protein (TBP, TaqMan assay ID: Hs00427620_ml), peptidylprolyl isomerase A (PPIA, TaqMan assay ID: Hs99999904_ml), and hypoxanthine phosphoribosyltransferase 1 (HPRT1, TaqMan assay ID: Hs99999909_ ml).
Quantitative reverse transcription-polymerase chain reaction
Polymerase chain reaction (PCR) primers and probes (TaqMan® gene expression assays) were purchased from Applied Biosystems. A total of 20 µl reaction mixture containing 10.0 µl of TaqMan gene expression master mix (2×), 1.0 µl of TaqMan gene expression assay (20×), 4 µl cDNA, and 5 µl H2O were added to each well of a Fast 96-well reaction plate (0.1 ml). Quantitative reverse transcription (qRT)-PCR was performed using primers for BMAL1 (TaqMan assay ID: Hs00154147ml), PER2 (TaqMan assay ID: Hs00256143ml), and nuclear receptor subfamily 1, group D, member 1 (NR1D1 [REB-ERBα], TaqMan assay ID: Hs00253876ml) on a StepOnePlus RealTime PCR System (Applied Biosystems). Thermal cycling conditions included 1 cycle at 50°C for 2 min, 1 cycle at 95°C for 10 min, and 40 cycles of amplification at 95°C for 15 s and 60°C for 1 min. The threshold cycle (Ct) was calculated automatically by the instrument software with a threshold value of 0.2 24) .
Measurement of catecholamine levels from right heart blood Catecholamine (i.e. adrenaline, noradrenaline, and dopamine) levels in serum from right heart blood were measured by means of high-performance liquid chromatography. Ranges for measurements were 62-722,970, 68-321,840, and 5-344,370 pg/ml for adrenaline, noradrenaline and dopamine respectively. Serum samples were diluted between 10-and 1,000-fold with saline before measurement. The accuracy and reliability of the tests were confi rmed for reproducibility with 10 serial dilutions, and non-reproducible data were not considered. Clinical serum reference ranges for catecholamines in peripheral blood were <100, 100-450 and <20 pg/ml for adrenaline, noradrenaline and dopamine respectively 23) .
Western blotting analysis
Tissues were lysed in cell lysis buff er (50 mM Tris-HCl [pH 8.0], 0.1% Triton X-100, 250 mM NaCl, 2 mM EGTA, 1 mM Na3VO4, and a protease inhibitor cocktail tablet [Complete Mini; Roche, Mannheim, Germany]), and the total amount of soluble proteins was quantified using the DC protein assay kit (Bio-Rad, Hercules, CA). Protein samples were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (10% gel for BMAL1, REV-ERBα, TBP and β-actin, and 10% for PER2), and the resolved proteins were transferred to nitrocellulose membranes (GE Healthcare, Buckinghamshire, UK). The membranes were blocked with 5% skim milk (Wako Pure Chemical, Osaka, Japan) and incubated with the primary antibodies followed by horseradish peroxidase-conjugated secondary antibody (GE Healthcare). The primary antibodies used were rabbit anti-human BMAL1 polyclonal antibody (sc-48790, 1:1000; Santa Cruz Biotechnology, Dallas. TX, USA) 27) , mouse anti-human PER2 monoclonal antibody (sc-377290, 1:1000; Santa Cruz Biotechnology) 28) , mouse anti-human REV-ERBα monoclonal antibody (sc-393215, 1:1000; Santa Cruz Biotechnology) 29) , rabbit anti-human TBP polyclonal antibody (22006-1-AP, 1:2000; Proteintech) 30) , anti-β-actin mouse monoclonal antibody (sc-47778, 1:1000; Santa Cruz Biotechnology) 31) . The immunoreactive signals were visualized with chemiluminescent detection using the AE-9300 Ez-Capture MG (ATTO, Tokyo, Japan). Protein quantitative analysis was performed with a CS Analyzer (ATTO) 32) .
Immunostaining for circadian clock proteins and catecholamines
Serial 4-µm sections were prepared from formalin-fi xed, paraffi nembedded tissue specimens from the left anterior ventricular wall. After deparaffinization, sections were immersed in 0.3% H 2 O 2 /phosphatebuff ered saline (PBS) for 10 min to inactivate endogenous peroxidase. After three washes with PBS for 5 min, specimens were incubated overnight with the following primary antibodies at empirically determined dilutions: rabbit anti-human BMAL1 polyclonal antibody (sc-48790, 1:50; Santa Cruz Biotechnology), mouse anti-human PER2 monoclonal antibody (sc-101105, 1:50; Santa Cruz Biotechnology) 33) , mouse anti-human REV-ERBα monoclonal antibody (119-14508, 1:100; Ray Biotech) 34) . Immunoreactivity was achieved by the polymer method using Dako Envison+ Dual Link System-HRP (K4063; Dako) and Dako Liquid DAB+ Substrate Chromogen System (K3468; Dako) according to the manufacturer's instructions 35) . 
Results

Validation of whole-genome microarray using qRT-PCR
First, we tested TBP, PPIA, HPRT1, GAPDH, and 18S to determine their validity for normalization using qRT-PCR. TBP was the most stable reference gene and was used for normalization.
Association of cardiopulmonary resuscitation with circadian clock gene expression and catecholamine levels
There were no signifi cant associations between cardiopulmonary resuscitation and changes in expression of circadian clock genes or catecholamine levels.
Acute ischemic heart disease
Circadian clock gene expression
BMAL1 expression showed a trimodal pattern over time with peaks in cases with times of death around 04:30, 10:30, and 21:00 in all sections of the myocardium, whereas PER2 showed a trimodal expression pattern that was in antiphase to that of BMAL1, with peaks in cases with times of death around 10:00, 14:00, and 23:00 in all sections of the myocardium. REV-ERBα expression, albeit showing greater variability, was generally trimodal and in the opposite direction of BMAL1 expression, with peaks in cases with times of death around 10:00, 14:00, and 23:00 (Figs.1, 2) .
Circadian clock immunohistological expression
Cytoplasmic BMAL1 immunostaining was strongly positive in cases with high BMAL1 expression, whereas cytoplasmic BMAL1 immunostaining was weakly positive in those with low BMAL1 expression. Conversely, cytoplasmic PER2 immunostaining was intense and nuclear PER2 immunostaining was weak in cases with high PER2 expression, whereas nuclear PER2 immunostaining was intense and cytoplasmic PER2 immunostaining was weak in cases with low PER2 expression. Finally, cytoplasmic REV-ERBα immunostaining tended to be intense in cases with higher REV-ERBα expression.
Catecholamine levels in right heart blood
Catecholamine levels within the day ranged between 5 and 565,409 pg/ml (adrenaline, 428-565,409 pg/ml [median, 43,374]; noradrenaline, 380-241,359 pg/ml [median, 54,374]; and dopamine 5-19,161 pg/ml [median, 1, 281] ). Blood catecholamine levels of adrenaline and noradrenaline, but not of dopamine, showed a trimodal pattern. At 10:00, adrenaline, noradrenaline, and dopamine levels were 258,363, 140,355, and 2,259 pg/ml respectively. At 14:00, adrenaline, noradrenaline, and dopamine levels were 319,412, 124,007, and 3,397 pg/ml respectively. At 23:00, adrenaline, noradrenaline, and dopamine levels were 565,409, 241,359, and 6,873 pg/ml respectively. Catecholamine levels obtained from right heart blood exhibited a time pattern similar to that of PER2 gene expression. In contrast, the timeassociated patterns of adrenaline and noradrenaline levels in blood were contrary to the BMAL1 expression pattern. Finally, the blood dopamine secretion pattern was unrelated to the BMAL1and PER2 expression patterns (Fig. 3) .
Western blot analysis
The results of PER2, REV-ERBα gene expression and the results of Western blotting were nearly all different, except for the results of BMAL1 on Western blot, which were in some cases similar to the results of mRNA expression. However, PER2 mRNA expression and the Western blot results were not well correlated, as PER2 protein levels on Western blot were low in almost all cases. Results for REV-ERBα on Western blot were also quite variable to mRNA levels (Figs.
1, 2).
Acute myocardial infarction Circadian clock gene expression
The BMAL1 expression curve was trimodal, with peaks in cases with times of death around 01:30, 07:30, and 14:00 in all sections of the myocardium, whereas PER2 expression exhibited a bimodal circadian variation in antiphase to BMAL1 expression, with peaks in cases with times of death around 05:00 and 14:00 in all sections of the myocardium. REV-ERBα expression, albeit showing variability, was generally in antiphase to that of BMAL1 and was bimodal, with peaks in cases with times of death around 05:00 and 10:00 (Figs. 4, 5) .
Circadian clock immunohistological expression
Cytoplasmic BMAL1 immunostaining was strongly positive in cases with high BMAL1 expression, whereas cytoplasmic BMAL1 immunostaining was weakly positive in those with low BMAL1 expression. Cytoplasmic PER2 immunostaining was strongly positive and nuclear PER2 immunostaining was weakly positive in cases with high PER2 expression, whereas nuclear PER2 immunostaining was strongly positive and cytoplasmic PER2 immunostaining was weakly positive in those with low PER2 expression. Finally, both cytoplasmic and nuclear REV-ERBα immunoreactivities were variable. 
Catecholamine levels in right heart blood
Over the day, catecholamine levels ranged between 5 and 722,970 pg/ml (adrenaline, 1,225-722,970 pg/ml [median, 178,122]; noradrenaline, 940-321,840 pg/ml [median, 117,215]; and dopamine, 5-344,370 pg/ml [median, 4, 535] ). Blood catecholamines, particularly adrenaline, but not dopamine, showed a trimoda1 pattern. At 01:30, adrenaline, noradrenaline and dopamine levels were 381,978, 161,825 and 1,241 pg/ml respectively. At 07:30, adrenaline, noradrenaline and dopamine levels were 510,101, 117,215 and 6,197 pg/ml respectively. The catecholamine levels of the two persons who died at about the same time (14:00) were similar (adrenaline: 580,666 pg/ml and 722,920 pg/ml; noradrenaline: 293,531 pg/ml and 321,840 pg/ ml; and dopamine: 4,498 pg/ml and 4,535 pg/ml). This pattern was comparable to that of BMAL1 expression. However, blood adrenaline and noradrenaline levels were in antiphase to the PER2 expression pattern. Additionally, blood dopamine levels were not related to the BMAL1 and PER2 expression patterns (Fig. 6) .
Western blot analysis
The results of Western blotting for BMAL1 were in some cases similar to the mRNA expression. However, PER2 mRNA expression did not correlate well with Western blot results for PER2 protein, which was low in almost all cases. Poor correlation between REV-ERBα Western blot results and the mRNA levels was also found (Figs. 
4, 5).
Recurrent myocardial infarction Circadian clock gene expression
In cases with death due to recurrent myocardial infarction, the BMAL1 expression curve was unimodal, with a peak in cases with times of death around 24:00 in all sections of the myocardium, whereas the PER2 expression curve showed an antiphasic unimodal pattern, peaking in cases with times of death around 11:30, except for one region of the myocardium. In contrast, REV-ERBα expression was variable. (Figs. 7, 8) 
Circadian clock immunohistological expression
According to the results of i mmunohistological st aining, cytoplasmic BMAL1 immunostaining was strongly positive in specimens with high BMAL1 expression, whereas cytoplasmic BMAL1 immunostaining was weakly positive in those with low BMAL1 expression. Cytoplasmic PER2 immunostaining was strongly positive and nuclear PER2 immunostaining was weakly positive in cases with high PER2 expression, whereas nuclear PER2 immunostaining was strongly positive and cytoplasmic PER2 immunostaining was weakly positive in those with low PER2 expression. Similar to the findings for AMI, both cytoplasmic and nuclear REV-ERBα immunoreactivity was variable.
Catecholamine levels in right heart blood
Blood catecholamine levels of RMI cases did not correlate with the expression levels of BMAL1, PER2, or REV-ERBα (Figs. 9) .
Western blot analysis
The result of Western blotting for BMAL1 and PER2 varied more than the mRNA expression levels. Similarly, REV-ERBα protein and mRNA levels were not well correlated (Figs. 7, 8 ).
Discussion
The present study comprises 33 males and 3 females. In view of the limited number of cases and the unavoidable inhomogeneity of the material, the investigations have to be regarded as a pilot study, which Naoto Tani et al.: Clock Genes in Sudden Cardiac Death Adrenarine Noradrenaline Dopamine should be continued on a broader basis. Therefore, the results and conclusions should be taken as preliminary but encouraging. While there was a clear male predominance in the cases studied, the fi ndings in the three females did not diff er from those in the males in terms of mRNA levels. In addition, we have previously published the results of blood catecholamine levels, showing no diff erences between males and females 23) . Another question is whether a prolonged postmortem interval influenced the results. On this point, we have previously reported postmortem stability of mRNA levels in the myocardium and blood catecholamine levels in examinations up to three days after death. For the present study, samples were generally assessed within 2 days of death. Furthermore, we have not observed changed in mRNA levels when samples are saved at -80 degrees 24, 36) . It is important that we consider about fundamental assumption underlying this study concerning accurate timing of the fatal event. Postmortem time and survival time based on descriptions of abnormal fl uidity of the blood seen at autopsy in acute death are part of forensic mythology and can be dismissed with little discussion, based on a recently published book 20) . Postmortem clotting in the heart and venous system is a most erratic process, as is the eventual dissolution of those clots by fi brinolytic enzyme. The diagnosis of acute death is considered to be unrelated to the lack of clotting in the heart. However, the survival time was defi ned as two parameters, the "classic signs" of acute death 20) as assessed on autopsy fi ndings and circumstantial evidence in autopsy documents, including information police investigations. This same "circumstantial evidence" in the autopsy documents was therefore also used to determine the postmortem time.
Among AIHD cases, we observed a trimodal BMAL1 expression pattern in all sections of the myocardium with peaks in cases with times of death around 04:30, 10:30, and 21:00, whereas the expression pattern of PER2, also trimodal, was in antiphase to that of BMAL1 with peaks in cases with times of death around 10:00, 14:00, and 23:00. These changes correlated with blood levels of catecholamines except for dopamine, which correlated with PER2 gene expression, but not BMAL1 or REV-ERBα. Among AMI cases, there was a correlation between adrenaline and noradrenaline levels in blood and BMAL1 expression, which showed a trimodal pattern with peaks in cases with times of death around 01:30, 07:30, and 14:00 in all sections of the myocardium; however, similar correlations between catecholamines and PER2 or REV-ERBα expression were not observed in AMI cases. Two AMI cases with death at 14:00 concerned one male and one female. Their test results were similar. However, the presence of any gender-dependent diff erences has to be examined in further studies.
Among RMI cases, the BMAL1 expression curve was unimodal, with a peak in cases with times of death around 24:00 in all sections of the myocardium, whereas the PER2 expression curve showed a unimodal pattern in antiphase to the BMAL1 expression pattern, peaking in cases with times of death around 11:30 in all sections of the myocardium except for one section. No correlations were noted between blood adrenaline and noradrenaline levels and BMAL1, PER2, or REV-ERBα expression in RMI cases.
There was no remarkable diff erence in the expression of the clock genes in the five collection parts of the heart, probably because the expression of the clock gene does not depend on myocardial ischemia.
There was no correlation between blood dopamine levels and the expression of circadian clock genes in any of the cases. Catecholamine levels were generally higher during the day than at night. The amplitudes of responses were shown to positively correlate with the 24-h mean values of catecholamines 37) . However, the results in the present study revealed that changes of catecholamine levels were greater in response to several pathophysiological conditions than with general circadian rhythm. But the underlying cause of relatively limited changes in dopamine levels compared to those detected in adrenaline and noradrenaline levels remains unknown. Adrenaline and noradrenaline are derived from metabolic modification of dopamine, which partially could explain the variation observed in blood dopamine levels in the present study. Catecholamine levels in the blood, cerebrospinal fl uid, pericardial fl uid, and urine, as for the secretion of dopamine, were unstable in our previous postmortem human studies 23, 38, 39) . Western blotting using autopsy samples did not correlate with the results of mRNA examination, so the immunohistochemical examination gave clearer results. However, we have provided the results of Western blotting. In AIHD and AMI, the assessment of PER2, REV-ERBα gene expression showed almost no correlation with protein levels from Western blot analysis. In some of the cases, Western blot results for BMAL1 were similar to the results for mRNA expression. However, PER2 levels are almost uniformly low on Western blotting, showing no relationship to PER2 mRNA expression. In RMI, the Western blot results for BMAL1 and PER2 varied more than did mRNA expression levels. Western blot results for REV-ERBα in AIHD, AMI and RMI, were more consistent with the mRNA levels. BMALl modulates the transcriptional activity of various genes through the transcriptional regulatory region E-box. Increased BMA L1 expression lead s t o t he act ivat ion of genes locate d downstream of the E-box sequence. In BMAL1-knockout mice, expression levels of various genes were shown to be reduced with resultant reductions in blood catecholamine levels, indicating that BMAL1 might control catecholamines 40) . The results of the present study showed that increased BMAL1 gene expression in AMI was associated with elevated blood catecholamine levels, suggesting that BMALl might activate catecholamine release upon the onset of AMI. Furthermore, PER2 gene expression was found to be correlated with blood catecholamine levels in AIHD, suggesting that during ischemic conditions such as myocardial infarction, BMAL1 may not be properly activated and death might occur due to pathological conditions such as arrhythmia. In AMI, BMAL1 probably controls catecholamines during the local ischemia that precedes the onset of myocardial infarction. In RMI, no examined clock gene expression pattern correlated with blood catecholamine levels. As myocardial infarction occurs repeatedly in RMI, myocardial fi brosis is widespread, and cardiomyocyte function is compromised. Additional pathological events such as arrhythmia and focal myocardial necrosis, which accompany recurrent myocardial infarction, are potential confounding factors underlying the observed variations in blood catecholamine levels in RMI.
Previous studies reported that adrenaline/noradrenaline levels in right heart blood were not affected by emergency treatment, whereas blood dopamine levels were affected 23) . Therefore, patients treated with catecholamines and those successfully resuscitated were excluded from this study. Moreover, no cardiovascular drugs, such as beta blockers, were detected on toxicology testing in our cases.
In summary, our findings suggest that differences in etiologies and time of death af ter onset between AIHD and AMI might contribute to differences in correlations between circadian clock gene expression and blood catecholamine levels. However, in several AMI cases, death occurred at a time period of low BMAL1 and blood catecholamine levels, suggesting the involvement of factors other than catecholamines, such as blood pressure-regulatory factors (e.g., renin-angiotensin-aldosterone) 41) and antifi brinolytic system factors 42) .
